Literature DB >> 30178869

Review article: the relationship between obesity, bariatric surgery, and inflammatory bowel disease.

Fiorella Cañete1,2,3, Míriam Mañosa1,2, Ariadna Clos1, Eduard Cabré1,2, Eugeni Domènech1,2.   

Abstract

BACKGROUND: The convoluted relationship between obesity, bariatric surgery and inflammatory bowel disease (IBD) is of increasing interest. AIM: To analyse evidence regarding the role of bariatric surgery in the development of de novo IBD and its impact on clinical outcomes and safety in patients with established IBD.
METHODS: A PubMed/Medline search was performed to identify studies reporting the development of IBD after bariatric surgery and the outcomes of IBD patients after bariatric surgery.
RESULTS: Eighty patients were reported to have developed de novo IBD after bariatric surgery (21% ulcerative colitis [UC], 75% Crohn's disease [CD]), mostly females. Roux-en-Y gastric bypass was the most frequent bariatric technique (80%). Symptoms related to IBD occurred within 1 month and 16 years after surgery. Regarding patients with known IBD undergoing bariatric surgery, 60 patients (35 CD, 24 UC, and 1 unclassified colitis) have been reported. Sleeve gastrectomy was the most frequent bariatric procedure, particularly in CD patients. Acute flares after surgery were observed in only four UC patients. In addition, two retrospective population-based studies described perioperative outcomes of bariatric surgery on IBD patients, demonstrating only a significant increase in small bowel obstruction in these patients.
CONCLUSIONS: Bariatric surgery in carefully selected patients with established IBD is technically feasible and probably safe. Development of de novo IBD should be taken into account in individuals with previous bariatric surgery who develop diarrhoea, anaemia or excessive weight loss.
© 2018 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 30178869     DOI: 10.1111/apt.14956

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

1.  Impact of Obesity on the Management of Inflammatory Bowel Disease.

Authors:  Amanda M Johnson; Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-07

2.  Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.

Authors:  Manuel B Braga Neto; Martin H Gregory; Guilherme P Ramos; Fateh Bazerbachi; David H Bruining; Barham K Abu Dayyeh; Vladimir M Kushnir; Laura E Raffals; Matthew A Ciorba; Edward V Loftus; Parakkal Deepak
Journal:  Inflamm Bowel Dis       Date:  2020-06-18       Impact factor: 5.325

3.  Bariatric Surgery and Risk of New-onset Inflammatory Bowel Disease: A Nationwide Cohort Study.

Authors:  Kristine H Allin; Rikke K Jacobsen; Ryan C Ungaro; Jean-Frederic Colombel; Alexander Egeberg; Marie Villumsen; Tine Jess
Journal:  J Crohns Colitis       Date:  2021-09-25       Impact factor: 9.071

4.  Essential updates 2018/2019: Colorectal (benign): Recent updates (2018-2019) in the surgical treatment of benign colorectal diseases.

Authors:  Takayuki Ogino; Tsunekazu Mizushima; Chu Matsuda; Masaki Mori; Yuichiro Doki
Journal:  Ann Gastroenterol Surg       Date:  2019-12-16

Review 5.  Secondary causes of inflammatory bowel diseases.

Authors:  Yezaz A Ghouri; Veysel Tahan; Bo Shen
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

Review 6.  What was First, Obesity or Inflammatory Bowel Disease? What Does the Gut Microbiota Have to Do with It?

Authors:  Sara Jarmakiewicz-Czaja; Aneta Sokal; Rafał Filip
Journal:  Nutrients       Date:  2020-10-08       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.